Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 5H95B | — |
5 months and 17 days that was inadvertently given the kinrix vaccine; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 5-month-old female patient who received DTPa-IPV (Kinrix) (batch number 5H95B, expiry date 16-FEB-2026) for prophylaxis. On 27-MAR-2025, the patient received Kinrix. On 27-MAR-2025, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: 5 months and 17 days that was inadvertently given the kinrix vaccine). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 27-MAR-2025 The clinic director reported that they had a patient who was 5 months and 17 days that was inadvertently given the Kinrix vaccine. The reporter just wanted to know if that was not harmful. The reporter did not know what number of Dtap-ipv dose was or which vaccine was supposed to be administered instead of Kinrix. The patient received a dose of Kinrix at an inappropriate age, which led to inappropriate age at vaccine administration.